• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, February 17, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Government’s teleheath ‘reticence’ hindering COVID-19 recovery

by rhiannon bowman
August 14, 2020
in Local, News
Reading Time: 2 mins read
A A
The survey involved 3,290 optometrists from across Australia.

The survey involved 3,290 optometrists from across Australia.

Share on FacebookShare on Twitter

Newly released data from Optometry Australia (OA) has revealed the detrimental impact of the first wave of the COVID-19 pandemic on the eye health sector, underlining the need for government support of telehealth optometry.

On 12 August, the peak professional body released the results of a survey it conducted in late May involving 3,290 members to understand the impact of the initial lockdown on the profession.

Lyn Brodie.

OA revealed that more than 90% of its members closed their practices or scaled back their hours of operation at the height of the pandemic in April.

At the same time, 96% of practice owners and self-employed optometrists saw their revenue decrease with a quarter seeing their income decline by 75% or more. The pandemic also contributed to a 74% plummet in Medicare patient consultations in April, with 192,720 performed compared with 749,780 in the same month of 2019.

CEO Ms Lyn Brodie said OA’s research indicates that it will probably be some time yet before optometry, in general, returns to pre-COVID conditions.

“We believe that around 50% of optometrists in Australia are currently working fewer hours now than they were pre-COVID-19. It is critical that they can return to optimal working capacity as quickly as possible to support community eye health needs,” Brodie said.

  • Click here for an infographic containing the key findings. 

She said the Federal Government’s reticence to include Medicare rebates for telehealth optometry is exacerbating the sector’s recovery, and therefore the ability to ensure quality eyecare for the whole community.

“We believe access to telehealth would have enabled many more practices to support patients during the height of the pandemic and likewise, could encourage more people to access the eye health care they need now,” she said.

Brodie noted that consumers are increasingly embracing technology as part of their health regime and the ongoing pandemic may likely accelerate this behaviour.

“It is therefore important that the Government supports telehealth optometry so that we can be certain that our profession is in a strong position to meet the eye health needs of patients who are unable to access face-to-face care,” she said.

OA’s research also highlights that in April, 77% of practice owners reduced their staffing levels and more than 90% of optometrists moved to some form of Government financial support with the majority of employers and employees accessing JobKeeper.

More reading:

Missed appointments data brings COVID-19 impact into focus

Upward trajectory: Eyecare sector charts recovery path

 

Tags: COVID-19impactLyn BrodieMedicareOAOptometry Australiapandemicrevenuesurvey

Related Posts

Amy Gollschewsky. Image: Specsavers

Specsavers Stories – Amy Gollschewsky

by Staff Writer
February 17, 2026

When people decide to work at Specsavers, they’re joining a company with a purpose to change lives through better sight and...

UNSW is the recipient of the $10.8 million grant. Image: Wirestock Creators/stock.adobe.com.

$10.8 million gift establishes new AMD research chair at UNSW

by Staff Writer
February 17, 2026

UNSW Sydney has established the Shirley and John Sarks Chair in Age-related Macular Degeneration after receiving a $10.8 million philanthropic...

Smart glasses are seen as the next big advance in wearable technology. Image: EssilorLuxottica.

Sales of AI smart glasses push 18% jump in EssilorLuxottica revenue

by Staff Writer
February 17, 2026

The world’s biggest eyewear maker is riding a surge in demand for AI glasses, reporting a significant rise in fourth-quarter...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited